Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters

The biosimilar concept is now well established. Clinical data accumulated pre- and post-approval have supported biosimilar uptake, in turn stimulating competition in the biologics market and increasing patient access to biologics. Following technological advances, other innovative biologics, such as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:MAbs
Autores principales: Kim, HoUng, Alten, Rieke, Cummings, Fraser, Danese, Silvio, D’Haens, Geert, Emery, Paul, Ghosh, Subrata, Gilletta de Saint Joseph, Cyrielle, Lee, JongHyuk, Lindsay, James O., Nikiphorou, Elena, Parker, Ben, Schreiber, Stefan, Simoens, Steven, Westhovens, Rene, Jeong, Ji Hoon, Peyrin-Biroulet, Laurent
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2021
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889098/
https://ncbi.nlm.nih.gov/pubmed/33557682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2020.1868078
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares